Zu "847499-27-8" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
![Delanzomib [CEP-18770]](https://www.biomol.com/media/image/dd/19/42/AG-CR1-3673-M001_200x200.png "Delanzomib [CEP-18770]")
Delanzomib [CEP-18770]
Artikelnummer: AG-CR1-3673-M005
Synthetic. Chemical. CAS: 847499-27-8. Formula: C21H28BN3O5. MW: 413.3. Synthetic. Potent, selective, reversible orally bioavailable proteasome inhibitor. Synthetic P2 threonine boronic acid. Targets the chymotrypsin-like beta5 subunit of the constitutive 20S proteasome (IC50=3.8nM). Cross-reacts and inhibits the...
| Schlagworte: | NPH 007098, CT 47098, CIP 18770,... |
| Anwendung: | Proteasome inhibitor |
| CAS | 847499-27-8 |
| MW: | 413,3 D |
ab 33,00 €
Delanzomib
Artikelnummer: Cay23557-1
Delanzomib is an orally bioavailable inhibitor of chymotrypsin-like proteasome activity (IC50 = 3.8 nM in isolated human erythrocytes) that only marginally inhibits tryptic and peptidyl glutamyl proteasome activity. Delanzomib pre-treatment (20 nM) in vitro inhibits IkappaBalpha degradation, NF-kappaB activation,...
| Schlagworte: | CEP-18770,... |
| Anwendung: | Antineoplastic, proteasome inhibitor |
| CAS | 847499-27-8 |
| MW: | 413.3 D |
ab 49,00 €
Delanzomib
Artikelnummer: TGM-T6027-100mg
Description: Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome. Target: Proteasome, Apoptosis, NF-kappaB. Smiles:...
| Schlagworte: | CEP-18770 |
| Anwendung: | Targets 20S proteasome subunit beta 6 [EC:3.4.25.1] (PSMB1) |
| CAS | 847499-27-8 |
| MW: | 413.28 D |
ab 37,00 €
